Charles Schwab
ORKA

Charles Schwab’s Oruka Therapeutics ORKA Stock Holding History

Charles Schwab’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.8M Sell
321,949
-7,547
-2% -$262K ﹤0.01% 1872
2025
Q4 		$9.99M Buy
329,496
+82,570
+33% +$2.3M ﹤0.01% 2145
2025
Q3 		$4.75M Buy
246,926
+162,924
+194% +$2.41M ﹤0.01% 2462
2025
Q2 		$942K Buy
84,002
+68,394
+438% +$713K ﹤0.01% 2920
2025
Q1 		$160K Hold
15,608
– – ﹤0.01% 3282
2024
Q4 		$303K Buy
+15,608
New +$381K ﹤0.01% 3268
2024
Q3 		– Sell
-1,249
Closed -$57.4K – 3615
2024
Q2 		$57.4K Hold
1,249
– – ﹤0.01% 3500
2024
Q1 		$26.7K Hold
1,249
– – ﹤0.01% 3422
2023
Q4 		$25.5K Hold
1,249
– – ﹤0.01% 3466
2023
Q3 		$30.1K Hold
1,249
– – ﹤0.01% 3467
2023
Q2 		$30.4K Hold
1,249
– – ﹤0.01% 3504
2023
Q1 		$29.8K Buy
+1,249
New +$32.9K ﹤0.01% 3448

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return